Response to "can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?": evaluation of CYP3A activity with microdoses of midazolam
- PMID: 24503628
- DOI: 10.1038/clpt.2014.28
Response to "can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?": evaluation of CYP3A activity with microdoses of midazolam
Comment on
-
A nanogram dose of the CYP3A probe substrate midazolam to evaluate drug interactions.Clin Pharmacol Ther. 2013 Jun;93(6):564-71. doi: 10.1038/clpt.2013.27. Epub 2013 Feb 8. Clin Pharmacol Ther. 2013. PMID: 23511711 Clinical Trial.
-
Can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?Clin Pharmacol Ther. 2014 May;95(5):489. doi: 10.1038/clpt.2014.6. Epub 2014 Jan 10. Clin Pharmacol Ther. 2014. PMID: 24518656 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources